翰思艾泰生物医药科技（武汉）股份有限公司（股票代码：03378，股票名称：翰思艾泰-B）于2026年5月12日发布翌日披露报表。公告显示，公司当日于香港联交所场内回购普通股2.49万股H股，占该次回购前已发行股份总数约0.018%，最高回购价为每股港币32.5元，最低回购价为每股港币31.5元，合计动用约79.25万港元。
本次回购完成后，公司已发行股份总数维持为136,218,830股，库藏股数量增至572,200股。公司于2026年2月12日获股东大会通过回购授权，允许回购最多13,621,883股，截至目前已在本交易所共计回购572,200股，占回购授权通过日已发行股本的约0.4201%。公告显示，下一次新股发行或库藏股再出售前需遵守截至2026年6月11日的暂止期。
公司确认已遵守香港联交所证券上市规则及相关法律法规。公告由董事长兼执行董事张发明签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.